Skip to main content

Bio-Rad Laboratories(BIO-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low280.35
Day High288.49
Open:281.61
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Bio-Rad Laboratories Stockholders Approve Directors and Governance Items
Bio-Rad Updates Investors on Sartorius Strategic Investment Metrics
Bio-Rad Laboratories Posts Mixed Q4 2025 Financial Results
Bio-Rad Laboratories (BIO) Gets a Hold from Wells Fargo
Bio-Rad Laboratories Reports Stable Q3 2025 Results
Bio-Rad Reports Q3 2025 Financial Results Amid Challenges
Bio-Rad Reports Third-Quarter 2025 Financial Results
Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025
Bio-Rad Laboratories Mourns Loss of Co-Founder Alice Schwartz
Bio-Rad Laboratories, Inc. Co-Founder and Director Emeritus Alice Schwartz Passes Away
Bio-Rad Laboratories (BIO) Gets a Buy from RBC Capital
Bio-Rad Laboratories (BIO) Gets a Buy from UBS
Bio-Rad Hosts Webinar on Digital PCR Advancements
Bio-Rad's Management to Participate in Upcoming Investor Conferences
Bio-Rad Laboratories’ Earnings Call Highlights Growth and Challenges
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Bio-Rad Laboratories (BIO)
Bio-Rad Reports Q2 2025 Financial Results
Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025
Bio-Rad Reports Second-Quarter 2025 Financial Results
Bio-Rad Laboratories Appoints New Executive VP for Growth
Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations
Bio-Rad to Report Second Quarter 2025 Financial Results on Thursday, July 31, 2025
Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout
Bio-Rad Laboratories (BIO) Receives a Buy from RBC Capital
Bio-Rad Completes Acquisition of Stilla Technologies
Analysts Offer Insights on Healthcare Companies: Bio-Rad Laboratories (BIO) and Ramsay Health Care (OtherRMSYF)

Profile

Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories.